Selling And Administration Expenses Endring Dato
AbbVie USD 3.61B 273M 2023-12
Aceragen USD 4.92M 32K 2023-03
Adma Biologics USD 16.22M 1.03M 2023-12
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Dynavax Technologies USD 39.79M 2.63M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Merck USD 2.75B 272M 2023-12
Minerva Neurosciences USD 2.64M 3.06K 2023-09
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
TG Therapeutics USD 31.15M 1.62M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Dynavax Technologies Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.